{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T22:04:51Z","timestamp":1790373891829,"version":"4.1.0"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["thebonejournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bone"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1016\/j.bone.2015.04.027","type":"journal-article","created":{"date-parts":[[2015,4,25]],"date-time":"2015-04-25T19:15:11Z","timestamp":1429989311000},"page":"115-119","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["The effects of bazedoxifene on bone structural strength evaluated by hip structure analysis"],"prefix":"10.1016","volume":"77","author":[{"given":"Thomas J.","family":"Beck","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Fuerst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth W.","family":"Gaither","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santosh","family":"Sutradhar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy B.","family":"Levine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Hines","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ching-Ray","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Mirkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arkadi A.","family":"Chines","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bone.2015.04.027_bb0005","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1097\/gme.0b013e3181c617e6","article-title":"Management of osteoporosis in postmenopausal women: 2010 position statement of The North American Menopause Society","volume":"17","author":"The North American Menopause Society","year":"2010","journal-title":"Menopause"},{"key":"10.1016\/j.bone.2015.04.027_bb0010","author":"U.S. Department of Health and Human Services"},{"key":"10.1016\/j.bone.2015.04.027_bb0020","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1007\/s00198-003-1460-x","article-title":"The contribution of hip fracture to risk of subsequent fractures: data from two longitudinal studies","volume":"14","author":"Colon-Emeric","year":"2003","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.bone.2015.04.027_bb0025","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1007\/s00198-006-0172-4","article-title":"An estimate of the worldwide prevalence and disability associated with osteoporotic fractures","volume":"17","author":"Johnell","year":"2006","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.bone.2015.04.027_bb0030","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1007\/s00198-005-0028-3","article-title":"Structural effects of raloxifene on the proximal femur: results from the multiple outcomes of raloxifene evaluation trial","volume":"17","author":"Uusi-Rasi","year":"2006","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.bone.2015.04.027_bb0035","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/BF00297293","article-title":"Sex differences in geometry of the femoral neck with aging: a structural analysis of bone mineral data","volume":"50","author":"Beck","year":"1992","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.bone.2015.04.027_bb0040","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1359\/jbmr.2001.16.11.2103","article-title":"Effects of current and discontinued estrogen replacement therapy on hip structural geometry: the study of osteoporotic fractures","volume":"16","author":"Beck","year":"2001","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bone.2015.04.027_bb0045","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.jocd.2008.04.001","article-title":"Effects of denosumab on the geometry of the proximal femur in postmenopausal women in comparison with alendronate","volume":"11","author":"Beck","year":"2008","journal-title":"J Clin Densitom"},{"key":"10.1016\/j.bone.2015.04.027_bb0050","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1007\/s00198-008-0762-4","article-title":"DXA-based hip structural analysis of once-weekly bisphosphonate-treated postmenopausal women with low bone mass","volume":"20","author":"Bonnick","year":"2009","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.bone.2015.04.027_bb0055","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1359\/jbmr.080707","article-title":"Hormone therapy improves femur geometry among ethnically diverse postmenopausal participants in the Women's Health Initiative hormone intervention trials","volume":"23","author":"Chen","year":"2008","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bone.2015.04.027_bb0060","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1359\/JBMR.050508","article-title":"Effect of hormone replacement, alendronate, or combination therapy on hip structural geometry: a 3-year, double-blind, placebo-controlled clinical trial","volume":"20","author":"Greenspan","year":"2005","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bone.2015.04.027_bb0065","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1007\/s00774-010-0164-5","article-title":"Effects of raloxifene treatment on the structural geometry of the proximal femur in Japanese women with osteoporosis","volume":"28","author":"Takada","year":"2010","journal-title":"J Bone Miner Metab"},{"key":"10.1016\/j.bone.2015.04.027_bb0070","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/j.bone.2005.03.003","article-title":"Effects of teriparatide [rhPTH (1-34)] treatment on structural geometry of the proximal femur in elderly osteoporotic women","volume":"36","author":"Uusi-Rasi","year":"2005","journal-title":"Bone"},{"key":"10.1016\/j.bone.2015.04.027_bb0075","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1359\/jbmr.080802","article-title":"Prediction of incident hip fracture risk by femur geometry variables measured by hip structural analysis in the study of osteoporotic fractures","volume":"23","author":"Kaptoge","year":"2008","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bone.2015.04.027_bb0080","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1007\/s00198-009-1056-1","article-title":"Hip structural geometry and incidence of hip fracture in postmenopausal women: what does it add to conventional bone mineral density?","volume":"21","author":"LaCroix","year":"2010","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.bone.2015.04.027_bb0085","doi-asserted-by":"crossref","first-page":"48","DOI":"10.2174\/1872214808666140118223801","article-title":"Recent methods for assessing osteoporosis and fracture risk","volume":"8","author":"Imai","year":"2014","journal-title":"Recent Pat Endocr, Metab Immune Drug Discov"},{"key":"10.1016\/j.bone.2015.04.027_bb0090","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1359\/jbmr.071206","article-title":"Effects of bazedoxifene on BMD and bone turnover in postmenopausal women: 2-yr results of a randomized, double-blind, placebo-, and active-controlled study","volume":"23","author":"Miller","year":"2008","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bone.2015.04.027_bb0095","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1359\/jbmr.080710","article-title":"Efficacy of bazedoxifene in reducing new vertebral fracture risk in postmenopausal women with osteoporosis: results from a 3-year, randomized, placebo-, and active-controlled clinical trial","volume":"23","author":"Silverman","year":"2008","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bone.2015.04.027_bb0100","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/1471-2474-11-130","article-title":"Safety of bazedoxifene in a randomized, double-blind, placebo- and active-controlled Phase 3 study of postmenopausal women with osteoporosis","volume":"11","author":"Christiansen","year":"2010","journal-title":"BMC Musculoskelet Disord"},{"key":"10.1016\/j.bone.2015.04.027_bb0105","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1007\/s00198-010-1302-6","article-title":"Safety and tolerability of bazedoxifene in postmenopausal women with osteoporosis: results of a 5-year, randomized, placebo-controlled phase 3 trial","volume":"22","author":"de Villiers","year":"2011","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.bone.2015.04.027_bb0110","doi-asserted-by":"crossref","DOI":"10.1097\/GME.0000000000000419","article-title":"A 7-year, randomized, placebo-controlled trial assessing the long-term efficacy and safety of bazedoxifene in postmenopausal women with osteoporosis: effects on bone density and fracture [published online ahead of print February 9, 2015]","author":"Palacios","year":"2015","journal-title":"Menopause"},{"key":"10.1016\/j.bone.2015.04.027_bb9000","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.maturitas.2013.06.008","article-title":"Assessment of the safety of long-term bazedoxifene treatment on the reproductive tract in postmenopausal women with osteoporosis: Results of a 7-year, randomized, placebo-controlled phase 3 study","volume":"76","author":"Palacios","year":"2013","journal-title":"Maturitas"},{"key":"10.1016\/j.bone.2015.04.027_bb0115","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s00198-011-1691-1","article-title":"Sustained efficacy and safety of bazedoxifene in preventing fractures in postmenopausal women with osteoporosis: results of a 5-year, randomized, placebo-controlled study","volume":"23","author":"Silverman","year":"2012","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.bone.2015.04.027_bb0120","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/j.bone.2009.02.014","article-title":"Bazedoxifene reduces vertebral and clinical fractures in postmenopausal women at high risk assessed with FRAX","volume":"44","author":"Kanis","year":"2009","journal-title":"Bone"},{"key":"10.1016\/j.bone.2015.04.027_bb0125","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1007\/s00198-013-2341-6","article-title":"An evaluation of the Fracture Risk Assessment Tool (FRAX) as an indicator of treatment efficacy: the effects of bazedoxifene and raloxifene on vertebral, nonvertebral, and all clinical fractures as a function of baseline fracture risk assessed by FRAX","volume":"24","author":"Kaufman","year":"2013","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.bone.2015.04.027_bb0130","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/j.bone.2009.01.373","article-title":"FRAX and its applications to clinical practice","volume":"44","author":"Kanis","year":"2009","journal-title":"Bone"},{"key":"10.1016\/j.bone.2015.04.027_bb0135","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1359\/jbmr.090402","article-title":"FRAX facts","volume":"24","author":"Watts","year":"2009","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bone.2015.04.027_bb0140","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1089\/jwh.2010.2294","article-title":"The Fracture Risk Assessment Tool (FRAX(R)): applications in clinical practice","volume":"20","author":"Watts","year":"2011","journal-title":"J Womens Health (Larchmt)"},{"key":"10.1016\/j.bone.2015.04.027_bb0145","series-title":"Technical report","article-title":"Assessment of osteoporosis at the primary health-care level","author":"Kanis","year":"2007"},{"key":"10.1016\/j.bone.2015.04.027_bb0150","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1210\/jc.2007-2814","article-title":"Effects of denosumab on bone mineral density and bone turnover in postmenopausal women","volume":"93","author":"Bone","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.bone.2015.04.027_bb0155","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s11914-007-0002-4","article-title":"Extending DXA, beyond bone mineral density: understanding hip structure analysis","volume":"5","author":"Beck","year":"2007","journal-title":"Curr Osteoporos Rep"}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328215001404?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328215001404?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,23]],"date-time":"2018-09-23T06:21:56Z","timestamp":1537683716000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S8756328215001404"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8]]},"references-count":31,"alternative-id":["S8756328215001404"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2015.04.027","relation":{},"ISSN":["8756-3282"],"issn-type":[{"value":"8756-3282","type":"print"}],"subject":[],"published":{"date-parts":[[2015,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The effects of bazedoxifene on bone structural strength evaluated by hip structure analysis","name":"articletitle","label":"Article Title"},{"value":"Bone","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bone.2015.04.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}